Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

Gabitass, RF, Annels, NE, Crawshaw, J, Pandha, HS and Middleton, GW (2011) Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Full text not available from this repository.

Item Type:	Article
Divisions :	Surrey research (other units)
Authors :	Name Email ORCID Gabitass, RF Annels, NE n.annels@surrey.ac.uk Crawshaw, J Pandha, HS h.pandha@surrey.ac.uk Middleton, GW
Date :	20 May 2011
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 10:13
Last Modified :	24 Jan 2020 18:46
URI:	http://epubs.surrey.ac.uk/id/eprint/826908

Actions (login required)

View Item

Downloads